We are officially living in the “maxxing” era. From “looksmaxxing” to improve appearance to “sleepmaxxing” for better rest, these viral terms all point to the same goal: squeezing every ounce of potential out of a specific trait or habit. With a growing focus on optimizing wellness and maximizing longevity, the trend has evolved into what’s known … Read more
Definium Therapeutics said a single dose of its LSD-based experimental pill significantly reduced symptoms of major depression in patients in a late-stage trial, sending its shares soaring 55% to a more than four-year high on Monday. The experimental drug helped patients record significantly lower scores on a standard depression scale than those on placebo after six weeks, … Read more
From shedding pounds and treating sleep apnea to lowering the risk of heart attacks, GLP-1s have rapidly evolved beyond their original purpose of treating Type 2 diabetes. Drugs like Ozempic and Wegovy are now being studied for a growing list of possible benefits, with early research pointing to possible effects on substance use disorders, neurodegenerative … Read more
The world’s largest and longest-running biohacking conference just wrapped — and peptides were among the hottest topics on the floor. It’s not hard to see why. In recent years, these experimental compounds have exploded across the worlds of longevity, beauty and fitness, with devotees touting benefits ranging from muscle building and injury recovery to slower … Read more
There’s new hope for one of the world’s deadliest cancers. Groundbreaking clinical trial results show that an experimental new drug could double survival time for pancreatic cancer patients. Patients taking the daily pill lived, on average, about six months longer than those who received chemotherapy alone — and had fewer side effects. Pancreatic cancer is … Read more
A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a sleep apnea drug called AD109. After various clinical trials, they are preparing to file for FDA approval. “A pill for sleep apnea has always been … Read more
Balding might make you blue — but this news won’t. A recent study suggests that a controversial liquid popular in biohacking and wellness circles could support scalp health and hair growth. Researchers say the substance may even hold promise for GLP-1 users with thinning crowns, a frustrating side effect that’s become increasingly common as the … Read more
A new treatment for endometrial cancer demonstrated strong potential in a Phase 3 clinical trial. Drugmaker Merck announced Monday that the investigational drug sacituzumab tirumotecan (sac-TMT) met its “primary endpoints” of overall survival and progression-free survival in patients with advanced or recurrent endometrial cancer. The TroFuse-005 trial is the first global Phase 3 trial to “demonstrate statistically significant … Read more
It’s a dose of disappointment. A supportive care drug that may help ease hyperactivity and improve speech and communication in children with autism has become so popular that desperate parents may have trouble getting their hands on it. Leucovorin — a reduced form of folate or vitamin B9, an essential nutrient our bodies can’t make … Read more
You’ve heard of pseudoscience — but what about celebrity science? New research suggests a bombshell claim from Mel Gibson on influencer Joe Rogan’s popular podcast may have helped fuel a dramatic surge in prescriptions for an unproven cancer treatment. During the January 2025 episode, which racked up more than 60 million views in its first … Read more
A hantavirus outbreak aboard a luxury cruise ship that has left three people dead is veering into the fringe. Online, a growing number of social media users are floating ivermectin as a possible treatment for the rare infectious disease, which can cause life-threatening heart and lung complications. Yes, you read that right — the antiparasitic … Read more
This surprising discovery may hold the key to calmer nerves. A new study out of Brazil found that a low dose of a common antibiotic, typically used to treat acne, rosacea and a range of bacterial infections, could also help people living with panic disorder. The findings suggest the drug might one day offer an … Read more
It’s not something to brush off. Hair loss is a widespread problem in the US, with roughly 50 million men and 30 million women experiencing pattern baldness. No special potion completely reverses genetic or age-related decline, but there are a few products that seem to halt further loss, thicken existing hair and promote regrowth. Now, … Read more
A mind-bending hallucinogen is moving out of the counterculture and into the clinic. The Food and Drug Administration on Friday greenlit the first-ever human clinical trial of an ibogaine derivative in the US, opening the door to testing the psychedelic drug as a potential treatment for alcohol-use disorder. The move comes just days after President … Read more
You might like the sound of this news. In a landmark move, the Food and Drug Administration on Thursday approved the first gene therapy for a rare, inherited form of hearing loss. And while these treatments often come with million-dollar price tags, Regeneron — the maker of Otarmeni — said it will be free for … Read more
A common acne medication may do more than clear skin. In a late-stage clinical trial, a higher concentration of it helped men with androgenetic alopecia (AGA) regrow and retain hair, with effects lasting over a year. “This is highly encouraging news for the millions of men affected by pattern hair loss, a chronic condition that … Read more
A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a “definite death sentence.” An experimental treatment from Revolution Medicines helped patients with an aggressive form of pancreatic cancer live twice as long as those on chemotherapy alone in a late-stage trial. But for … Read more
This news isn’t hard to swallow. Researchers at Yale University have identified a low-cost prescription drug already on the market that could help ease symptoms of autism spectrum disorder (ASD) in some people. And if you’re thinking it’s leucovorin — a vitamin B–derived drug hyped as a possible remedy — you’d be wrong. Approximately 1 … Read more
Former GOP Sen. Ben Sasse is opening up about living with what he describes as a “definite death sentence.” The 54-year-old father of three was diagnosed with Stage 4 pancreatic cancer last year, an aggressive disease he’s fighting with an experimental drug that has left his skin bloody and “bubbling.” “Here’s a hard fact: Ben … Read more
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and glucagon hormones, whereas most other drugs on the market only mimic one or two of those hormones. Eli Lilly’s new retatrutide drug … Read more